Genprex, Inc. Intellectual Property Contracts & Agreements
11 Contracts & Agreements
- License Agreements (11 contracts)
- Second Amendment to Exclusive License Agreement, dated November 3, 2022, by and between Genprex, Inc. and the University of Pittsburgh - Of the Commonwealth System of Higher... (Filed With SEC on April 1, 2024)
- Exclusive License Agreement, dated July 14, 2023 (Filed With SEC on July 18, 2023)
- Exclusive License Agreement, dated December 29, 2022 (Filed With SEC on January 5, 2023)
- Exclusive License Agreement, dated November 22, 2022 (Filed With SEC on November 28, 2022)
- First Amendment to Exclusive License Agreement, dated August 17, 2022 (Filed With SEC on August 22, 2022)
- Amendment No. 1 to Patent and Technology License Agreement, dated March 3, 2021, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center (Filed With SEC on March 26, 2021)
- Patent and Technology License Agreement dated as of May 4, 2020, by and between Genprex, Inc. and The Board of Regents of The University of Texas System (Filed With SEC on May 14, 2020)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on February 18, 2020)
- TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on August 18, 2017)
- AMENDMENT NO. 3 TO PATENT AND TECHNOLOGY LICENSE AGREEMENT DATED JULY 31,1994 (Filed With SEC on August 18, 2017)
- PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on August 18, 2017)
